Healthcare Equities

The companies that provide, support or coordinate medical goods and services. This sector spans a broad range of activities – including the development and manufacture of medical equipment, pharmaceuticals and other treatments. Activities range from research to manufacturing, administration, insurance and facilities management. Our Healthcare research includes healthcare services, healthcare information technology (IT), medical devices, biotechnology, biopharmaceuticals and specialty pharmaceuticals.

BioArctic (Nasdaq Stockholm: BIOA B) enters global license agreement with BMS >

Arron Aatkar | Healthcare | Comment | 2 days ago

BioArctic (Nasdaq Stockholm: BIOA B) enters global license agreement with BMS >

Arron Aatkar | Healthcare | Comment | 2 days ago

SEE ALL COMMENTARY >

Oryzon Genomics (ORY)

Latest price

EUR1.55

▾ −0.05 (−2.89)

As at 20/12/2024

Market capitalisation: EUR102m

View equity

edison tv

Healthcare

10.12.24

Oryzon Genomics – executive interview

Update

Healthcare

30.10.24

Oryzon Genomics — Q3 results recap key upcoming inflection points

Flash note

Healthcare

02.10.24

EUR7.11

▾ −0.06 (−0.84)

As at 20/12/2024

Market capitalisation: EUR156m

View equity

Update

Healthcare

21.11.24

OSE Immunotherapeutics — Full Lusvertikimab results reflect potential in UC

Update

Healthcare

09.10.24

OSE Immunotherapeutics — Riding the H124 tailwinds

Flash note

Healthcare

11.09.24

GBP0.00

— 0.00 (0.00)

As at 20/12/2024

Market capitalisation: GBP8m

View equity

Recce Pharmaceuticals (RCE)

Latest price

AUD0.45

▾ −0.02 (−3.23)

As at 20/12/2024

Market capitalisation: AUD105m

View equity

Flash note

Healthcare

17.12.24

Recce Pharmaceuticals — BPOM clearance to start Phase III R327G study

Update

Healthcare

02.12.24

Recce Pharmaceuticals — Topical R327G approaching pivotal stages

edison tv

Healthcare

22.11.24

GBP0.27

▾ −0.50 (−1.82)

As at 20/12/2024

Market capitalisation: GBP34m

View equity

edison tv

Healthcare

25.11.24

Sareum Holdings – executive interview

Update

Healthcare

12.11.24

Sareum Holdings — SDC-1801 prepping to enter Phase II

Flash note

Healthcare

11.10.24

USD6.03

▾ 0.30 (5.24)

As at 20/12/2024

Market capitalisation: USD431m

View equity

Update

Healthcare

18.11.24

SIGA Technologies — Strong order book moving into Q424

Flash note

Healthcare

23.08.24

SIGA Technologies — TPOXX chalks up another DoD contract win

Flash note

Healthcare

19.08.24

USD0.58

▾ −0.03 (−4.13)

As at 20/12/2024

Market capitalisation: USD54m

View equity

edison tv

Healthcare

24.10.24

Volition webinar: Nu.Q NETs data insights

edison tv

Healthcare

15.02.24

VolitionRx webinar: Unravelling the web of NETs in sepsis … Part II

Update

Healthcare

08.02.24

VolitionRx — Snaring sepsis, with early NETs detection

See more
content on

VolitionRx

Equities

Equities by Sector

Sectors

Thematics

Latest

Inside the mind of investors: International Biotechnology Trust

Borussia Dortmund – executive interviews

UK equities: A generational opportunity?

Audiovisual

Latest

Vantage: Gresham House Energy Storage Fund – Navigating challenges in energy storage

IP Group – executive interview

Georgia Capital in 60 seconds

About Edison

About Edison

Careers

Healthcare Equities

Oryzon Genomics (ORY)

EUR1.55

Oryzon Genomics – executive interview

Oryzon Genomics — Q3 results recap key upcoming inflection points

Oryzon Genomics — FDA aligns on Phase III BPD plans

See morecontent on

OSE Immunotherapeutics (OSE)

EUR7.11

OSE Immunotherapeutics — Full Lusvertikimab results reflect potential in UC

OSE Immunotherapeutics — Riding the H124 tailwinds

OSE Immunotherapeutics — Tedopi registrational study commences

See morecontent on

Percheron Therapeutics (PER)

GBP0.00

Recce Pharmaceuticals (RCE)

AUD0.45

Recce Pharmaceuticals — BPOM clearance to start Phase III R327G study

Recce Pharmaceuticals — Topical R327G approaching pivotal stages

Recce Pharmaceuticals – executive interview

See morecontent on

Sareum Holdings (SAR)

GBP0.27

Sareum Holdings – executive interview

Sareum Holdings — SDC-1801 prepping to enter Phase II

Sareum Holdings — New funding extends runway to Phase II

See morecontent on

SIGA Technologies (SIGA)

USD6.03

SIGA Technologies — Strong order book moving into Q424

SIGA Technologies — TPOXX chalks up another DoD contract win

SIGA Technologies — PALM 007 data warrant a closer look in mpox

See morecontent on

VolitionRx (VNRX)

USD0.58

Volition webinar: Nu.Q NETs data insights

VolitionRx webinar: Unravelling the web of NETs in sepsis … Part II

VolitionRx — Snaring sepsis, with early NETs detection

See morecontent on

Subscribe to Edison

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on